• 1. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 2. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 3. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 4. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 5. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126

Introduction to 2-Chloro-4-methylphenylhydrazine hydrochloride (CAS No. 227958-97-6)

2-Chloro-4-methylphenylhydrazine hydrochloride, identified by its Chemical Abstracts Service (CAS) number 227958-97-6, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and medicinal chemistry. This compound belongs to the phenylhydrazine class, which is widely recognized for its versatile applications in the synthesis of biologically active molecules. The presence of both chloro and methyl substituents on the aromatic ring introduces unique electronic and steric properties, making it a valuable intermediate in the development of novel therapeutic agents.

The< strong>structure of 2-Chloro-4-methylphenylhydrazine hydrochloride consists of a benzene ring substituted with a chloro group at the 2-position and a methyl group at the 4-position, linked to an hydrazine moiety. The hydrochloride salt form enhances its solubility in aqueous systems, facilitating its use in various biochemical assays and drug formulation processes. This compound has been extensively studied for its potential role in modulating enzymatic pathways and interacting with biological targets, particularly in the context of inflammation, neurodegeneration, and metabolic disorders.

In recent years, there has been a surge in research focused on developing small-molecule inhibitors for neurological disorders. 2-Chloro-4-methylphenylhydrazine hydrochloride has emerged as a promising candidate due to its ability to interact with specific protein targets involved in neuroinflammation and oxidative stress. Studies have demonstrated its potential in reducing pro-inflammatory cytokine production and mitigating oxidative damage in neuronal cells. These findings align with the growing interest in harnessing phenylhydrazine derivatives for their neuroprotective properties.

The< strong>pharmacological profile of 2-Chloro-4-methylphenylhydrazine hydrochloride has been further explored through preclinical studies, where it exhibited notable efficacy in animal models of neurodegenerative diseases. Its ability to cross the blood-brain barrier and exert targeted effects makes it an attractive option for developing treatments against conditions such as Alzheimer's disease and Parkinson's disease. Additionally, its interaction with monoamine oxidase (MAO) enzymes has been investigated, suggesting potential applications in managing mood disorders.

From a synthetic chemistry perspective, 2-Chloro-4-methylphenylhydrazine hydrochloride serves as a versatile building block for constructing more complex pharmacophores. The chloro and methyl substituents provide reactive sites for further functionalization, enabling the creation of derivatives with enhanced pharmacokinetic profiles. Recent advances in catalytic methods have allowed for more efficient synthesis routes, reducing the environmental impact while maintaining high yields. These innovations underscore the importance of optimizing synthetic methodologies to meet the demands of modern drug discovery.

The< strong>biological activity of this compound has also been linked to its ability to modulate signal transduction pathways involved in cell survival and apoptosis. Research indicates that 2-Chloro-4-methylphenylhydrazine hydrochloride can inhibit the activity of certain kinases and phosphatases, thereby influencing cellular processes critical for maintaining homeostasis. This mechanism of action has opened new avenues for exploring its therapeutic potential in cancer and autoimmune diseases.

In conclusion, 2-Chloro-4-methylphenylhydrazine hydrochloride (CAS No. 227958-97-6) represents a significant advancement in medicinal chemistry, offering a unique combination of structural features that make it suitable for diverse therapeutic applications. Its role in modulating neurological and inflammatory pathways underscores its importance as a lead compound for further drug development. As research continues to uncover new biological functions and synthetic strategies, this compound is poised to play a pivotal role in addressing some of the most pressing challenges in human health.

• 41052-75-9((2-chlorophenyl)hydrazine;hydrochloride)
• 90631-70-2((2-Chloro-4-methylphenyl)hydrazine)
• 60481-39-2(1-(2-Chloro-3-methylphenyl)hydrazine)
• 89187-46-2((2-Chloro-6-methylphenyl)hydrazine)
• 55034-69-0(Hydrazine,(2-chloro-4,6-dimethylphenyl)-)
• 10449-07-7(1-(2-Chlorophenyl)hydrazine)
• 187607-99-4(1-(2-chloro-5-methylphenyl)hydrazine)
• 254880-25-6(Benzonitrile,3-chloro-4-hydrazinyl-)
• 13147-14-3((2,3-Dichlorophenyl)hydrazine)
• 63134-30-5((2-chloro-4,6-dimethylphenyl)hydrazine hydrochloride)